WZC Heilig Hart vzw
Oudenaarde, 9700, Belgium
NCT Number: NCT05316012
The smart diaper aims to (1) detect humidity, (2) be capable of sending real-time indication of the saturation to the healthcare workers when urine loss occurs and (3) generate alerts when the diaper requires changing. Potential benefits of the smart diaper compared to incontinence management products without sensor technology include: workload reduction, increased comfort for residents and staff, more person-centred care, increased quality of care, less skin damage and economic (e.g. less costs due to less excessive diaper changes), and/or environmental (e.g. less waste) gains.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Oudenaarde, 9700, Belgium
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Residents receive standard continence care while using the smart diaper (without the alerting system) - fase 1
Diapers are changed as usual, e.g., after morning care, visual soiling, unpleasant odor, saturation, leakage.
Residents receive continence care while using the smart diaper with the alerting system - fase 2
Time frame: 10 days
The difference between the percentage saturation determined by the smart diaper and the percentage saturation based on the data registered in the frequency volume urine charts (FVUCs) (during each study period* for each diaper change)
Time frame: 10 days
= warning on saturation of the incontinence material) generated by the sensor.
a. Each warning generated by the sensor will be assessed by the nurse (correct/incorrect warning)
Time frame: 10 days
University Ghent
Other
Acronym: Smart Diapers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06206512
Cardiovascular Diseases, Female Urogenital Diseases
Dallas, Texas, United States
View Trial DetailsNCT06470620
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Haifa, Haifa District, Israel
View Trial DetailsNCT04491617
Agnosia, Incontinence
Cleveland, Ohio, United States
View Trial DetailsNCT05960734
Cancer, Incontinence
Oviedo, Principality of Asturias, Spain
View Trial Details